{
    "clinical_study": {
        "@rank": "74045", 
        "arm_group": [
            {
                "arm_group_label": "Group 1", 
                "arm_group_type": "Experimental", 
                "description": "Insertion of catheter into nasal cavity carried out by patient. Fixation of catheter during treatment with patient\u00b4s hand."
            }, 
            {
                "arm_group_label": "Group 2", 
                "arm_group_type": "Experimental", 
                "description": "Insertion of catheter into nasal cavity carried out by health professional. Fixation of catheter during treatment with helmet."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to evaluate how treatment with Kinetic Oscillation Stimulation\n      (KOS) in the nasal cavity in patients with non-allergic rhinitis can be optimized to\n      minimize any patient reported discomfort during treatment procedure."
        }, 
        "brief_title": "Kinetic Oscillation Stimulation (KOS) of Nasal Mucosa in Non-allergic Rhinitis: Investigation of Treatment Procedure", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Non-allergic Rhinitis.", 
        "condition_browse": {
            "mesh_term": "Rhinitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with persistent (>12w) symptoms of idiopathic rhinitis dominated by nasal\n             congestion (\u00b1 secretion) for an average of at least 1 h per day for at least 5 days\n             during a period of 14 days\n\n          -  Having nasal congestion as major symptom, and a nasal congestion score of at least 2\n             (scale 0-3)\n\n          -  Male or female 18 - 65 years\n\n          -  Judged by the Investigator as suitable for participation in the study without safety\n             concerns based on medical history and physical examination\n\n          -  Willing and able to provide written informed consent prior to participation in the\n             clinical investigation\n\n          -  Willing and able to comply with all study related procedure\n\n        Exclusion Criteria:\n\n          -  Patients with Allergic rhinitis, demonstrated by either positive skin prick test,\n             phadiatop or RAST(radioallergosorbent test)\n\n          -  Ongoing respiratory tract infection including nasal cavity at inclusion (treatment\n             visit 1)\n\n          -  Systemic steroid treatment less than 4 weeks before the inclusion in the study\n\n          -  Patients with a history of nasal surgery like: septoplasty, cosmetic surgery, conchal\n             surgery or any other nasal surgery except closed reposition for nasal fracture\n\n          -  History of frequent nose bleeds or a condition that increases the risk of excessive\n             bleeding\n\n          -  Pronounced anterior septal deviation or other significant nasal pathology at\n             endoscopic examination\n\n          -  Current malignancy of any kind\n\n          -  Known allergy to polyvinylchloride or medicinal liquid paraffin\n\n          -  Any disease, condition (medical or surgical) which, in the opinion of the\n             investigator, might compromise the study results, or would place the subject at\n             increased risk\n\n          -  Any implant with an electrical and/or neurostimulator device, including but not\n             limited to cardiac pacemaker, defibrillator, vagal neurostimulator, deep brain\n             stimulation, spinal stimulator, bone growth stimulator, or cochlear implant or any\n             other implant in the head-, and neck region\n\n          -  Previous treated with radiation on the face, head or neck regions\n\n          -  Female patients who are pregnant or nursing, or become pregnant at any time from\n             first visit at ENT(Ear, Nose and Throat) - clinic until treatment day (second visit)\n\n          -  Female patients: unwilling to use adequate contraceptive between first and last visit\n\n          -  Received study drug in a clinical trial for an investigational drug within the\n             previous 30 days, or 5 half-lives, whichever is longer"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02136043", 
            "org_study_id": "AHC14."
        }, 
        "intervention": {
            "arm_group_label": [
                "Group 1", 
                "Group 2"
            ], 
            "intervention_name": "PBASE system 1.1 (active treatment)", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 8, 2014", 
        "location": {
            "contact": {
                "email": "finn.jorgensen@regionhalland.se", 
                "last_name": "Finn Jorgensen, M.D., Ph.D.", 
                "phone": "004635-13 1460"
            }, 
            "contact_backup": {
                "email": "alexander.juto@regionhalland.se", 
                "last_name": "Alexander Juto, MSc Medicine", 
                "phone": "004635147876"
            }, 
            "facility": {
                "address": {
                    "city": "Halmstad", 
                    "country": "Sweden"
                }, 
                "name": "Ear, Nose and Throat Dept, Halmstad County Hospital"
            }, 
            "investigator": {
                "last_name": "Finn Jorgensen, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Study (With Active Treatment in Both Treatment Groups) to Evaluate How a New Vibration Treatment in the Nose in Patients With Non-allergic Rhinitis Can be Done as Convenient as Possible to the Patient", 
        "other_outcome": {
            "description": "To evaluate if treatment effect (assessed 15 minutes before treatment and 14 days after treatment) by PNIF is different between treatment groups.", 
            "measure": "Peak Nasal Inspiratory Flow (PNIF)", 
            "safety_issue": "No", 
            "time_frame": "Baseline, day 14"
        }, 
        "overall_official": {
            "affiliation": "Halmstad County Hospital", 
            "last_name": "Finn Jorgensen, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To evaluate whether patient\u00b4s self-administration of catheter into nasal cavity is associated with a different degree of patient-reported pain on Visual Analogue Scales (VAS) compared to when administered by a health professional.", 
            "measure": "Pain score on the Visual Analogue Scale", 
            "safety_issue": "No", 
            "time_frame": "Five seconds after placement of catheter in nasal cavity"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02136043"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Halmstad County Hospital", 
            "investigator_full_name": "Finn Jorgensen", 
            "investigator_title": "Finn Jorgensen, M.D., Ph.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "To evaluate if treatment effect (assessed 15 minutes before treatment and 14 days after treatment) by SNOT-22 is different between treatment groups.", 
            "measure": "Sino-Nasal Outcome Test-22 (SNOT-22) questionnaire", 
            "safety_issue": "No", 
            "time_frame": "Baseline, day 14"
        }, 
        "source": "Halmstad County Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Halmstad County Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}